Outsourcing STREAM

1. How To Take Advantage Of Early Access Programs For The EU 6/12/2024

   Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.

2. Improving Sponsor Oversight Of The Trial Master File 2/15/2023

   In the face of increasing documentation requirements and trial complexity, discover how global biopharmaceutical company Chiesi and its CRO partners collaborated to ensure ongoing oversight compliance.

3. Flipping The Drug Development Industry On Its Head 6/18/2024

   The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.

4. Successful Implementation Of A Drug-Device Combination Submission 11/21/2025

   Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.

5. Navigating The Unique Attributes Of Psychedelic Drug Development 1/22/2024

   Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.

6. An Innovative Approach To Functional Outsourcing 8/27/2025

   The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.

7. We Are Altasciences: Proactive Drug Development 1/30/2023

   When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.

8. Multi-Site Capabilities For Your Phase I-II Trials 5/1/2026

   Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired patient populations.

9. See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada 3/23/2023

   Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.

10. Mitigating Risk And Complexity In Cell & Gene Therapy Trials With IRT 8/19/2025

    CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.